Transitioning To A New Biobank Model At A Time Of Change

Source: Thermo Fisher Scientific

By Karen Roberts, Kerry Heathcote, Steve Jenkins, Steve Kelly, Richard Kilburn, Doug McKechnie, Louise Shaw, Zoe Taylor, Kate Enright, Leo Forster

Transitioning To A New Biobank Model At A Time Of Change

The AstraZeneca UK Biobank offers long-term storage of, and rapid access to, approximately 1 million human biological samples from AZ Oncology clinical trials, collaborators and commercial sources. In order to meet the increased demand for rapid access to high-quality samples, AZ partnered with Fisher Clinical Services to create a mixed outsourcing biobank model. To learn more about the challenges and benefits, download the infographic.

access the Infographic!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online